Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

ESSENTIAL Trial™ Sham Cross-over

ClinicalTrials.gov ID: NCT02279420

Public ClinicalTrials.gov record NCT02279420. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 2:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Supplemental Open Label Multicenter Sham Cross-over Clinical Trial Using an Endoscopic Suturing Device (g-Cath EZ™ Suture Anchor Delivery Catheter) For Primary Weight Loss Essential Study (IDE G130163) Crossover Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, un-blinded, open label, pivotal supplemental study to G130163 intended to evaluate the safety and efficacy of treating previous sham subjects in the Essential pivotal trial (IDE#G130163) with the active treatment (the placement of g-Cath EZ suture anchors along with diet and exercise). Compliant sham subjects (those who attended all primary IDE follow-up visits AND who continue to meet eligibility criteria as described in this protocol) will be offered this active treatment after their 12 month unblinding visit in the Essential pivotal trial.

Study identification

NCT ID
NCT02279420
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
USGI Medical
Industry
Enrollment
73 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
23 Years to 61 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 4, 2015
Primary completion
Aug 30, 2016
Completion
Sep 29, 2016
Last update posted
May 11, 2017

2015 – 2016

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
Shea Campus -Scottsdale Healthcare Scottsdale Arizona 85258
University of Miami Hospital Miami Florida 33166
Hamilton Medical Center Dalton Georgia 30720
Northshore/Evanston Hospital Evanston Illinois 60201
Crescent City Surgical Metairie Louisiana 70001
Brigham & Women's Hospital Boston Massachusetts 02115
Fairview UMMC-University Minneapolis Minnesota 55455
Saint Luke's Hospital Kansas City Missouri 64111
WA University School of Medicine St Louis Missouri 63110
Lexington Medical Center West Columbia South Carolina 29169
Baptist Memorial Hospital Memphis Tennessee 38120

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02279420, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 11, 2017 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02279420 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →